Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study

Abstract Background Supraclavicular block (SCB) with long-acting local anaesthetic is commonly used for surgical repair of distal radial fractures (DRF). Studies have shown a risk for rebound pain when the block fades. This randomised single-centre study aimed to compare pain and opioid consumption...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irén Sellbrant, Jon Karlsson, Jan G. Jakobsson, Bengt Nellgård
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/5f184597ed4f4df4b4fefff5125026d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5f184597ed4f4df4b4fefff5125026d6
record_format dspace
spelling oai:doaj.org-article:5f184597ed4f4df4b4fefff5125026d62021-11-14T12:11:49ZSupraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study10.1186/s12871-021-01499-z1471-2253https://doaj.org/article/5f184597ed4f4df4b4fefff5125026d62021-11-01T00:00:00Zhttps://doi.org/10.1186/s12871-021-01499-zhttps://doaj.org/toc/1471-2253Abstract Background Supraclavicular block (SCB) with long-acting local anaesthetic is commonly used for surgical repair of distal radial fractures (DRF). Studies have shown a risk for rebound pain when the block fades. This randomised single-centre study aimed to compare pain and opioid consumption the first three days post-surgery between SCB-mepivacaine vs. SCB-ropivacaine, with general anaesthesia (GA) as control. Methods Patients (n = 90) with ASA physical status 1–3 were prospectively randomised to receive; SCB with mepivacine 1%, 25–30 ml (n = 30), SCB with ropivacaine 0.5%, 25–30 ml (n = 30) or GA (n = 30) with propofol/fentanyl/sevoflurane. Study objectives compared postoperative pain with Numeric Rating Scale (NRS) and sum postoperative Opioid Equivalent Consumption (OEC) during the first 3 days post-surgery between study-groups. Results The three groups showed significant differences in postoperative pain-profile. Mean NRS at 24 h was significantly lower for the SCB-mepivacaine group (p = 0.018). Further both median NRS and median OEC day 0 to 3 were significanly lower in the SCB-mepivacaine group as compared to the SCB-ropivacaine group during the first three days after surgery; pain NRS 1 (IQR 0.3–3.3) and 2.7 (IQR 1.3–4.2) (p = 0.017) and OEC 30 mg (IQR 10–80) and 85 mg (IQR 45–125) (p = 0.004), respectively. The GA-group was in between both in pain NRS and median sum OEC. Unplanned healthcare contacts were highest among SCB-ropivacaine patients (39.3%) vs. SCB-mepivacaine patients (0%) and GA-patients (3.4%). Conclusions The potential benefit of longer duration of analgesia, associated to a long-acting local anaesthetic agent, during the early postoperative course must be put in perspective of potential worse pain progression following block resolution. Trial registration NCT03749174 (clinicaltrials.gov, Nov 21, 2018, retrospectively registered).Irén SellbrantJon KarlssonJan G. JakobssonBengt NellgårdBMCarticleDay surgeryDistal radial fractureLocal anaestheticsOpioid consumptionPostoperative painRebound painAnesthesiologyRD78.3-87.3ENBMC Anesthesiology, Vol 21, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Day surgery
Distal radial fracture
Local anaesthetics
Opioid consumption
Postoperative pain
Rebound pain
Anesthesiology
RD78.3-87.3
spellingShingle Day surgery
Distal radial fracture
Local anaesthetics
Opioid consumption
Postoperative pain
Rebound pain
Anesthesiology
RD78.3-87.3
Irén Sellbrant
Jon Karlsson
Jan G. Jakobsson
Bengt Nellgård
Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
description Abstract Background Supraclavicular block (SCB) with long-acting local anaesthetic is commonly used for surgical repair of distal radial fractures (DRF). Studies have shown a risk for rebound pain when the block fades. This randomised single-centre study aimed to compare pain and opioid consumption the first three days post-surgery between SCB-mepivacaine vs. SCB-ropivacaine, with general anaesthesia (GA) as control. Methods Patients (n = 90) with ASA physical status 1–3 were prospectively randomised to receive; SCB with mepivacine 1%, 25–30 ml (n = 30), SCB with ropivacaine 0.5%, 25–30 ml (n = 30) or GA (n = 30) with propofol/fentanyl/sevoflurane. Study objectives compared postoperative pain with Numeric Rating Scale (NRS) and sum postoperative Opioid Equivalent Consumption (OEC) during the first 3 days post-surgery between study-groups. Results The three groups showed significant differences in postoperative pain-profile. Mean NRS at 24 h was significantly lower for the SCB-mepivacaine group (p = 0.018). Further both median NRS and median OEC day 0 to 3 were significanly lower in the SCB-mepivacaine group as compared to the SCB-ropivacaine group during the first three days after surgery; pain NRS 1 (IQR 0.3–3.3) and 2.7 (IQR 1.3–4.2) (p = 0.017) and OEC 30 mg (IQR 10–80) and 85 mg (IQR 45–125) (p = 0.004), respectively. The GA-group was in between both in pain NRS and median sum OEC. Unplanned healthcare contacts were highest among SCB-ropivacaine patients (39.3%) vs. SCB-mepivacaine patients (0%) and GA-patients (3.4%). Conclusions The potential benefit of longer duration of analgesia, associated to a long-acting local anaesthetic agent, during the early postoperative course must be put in perspective of potential worse pain progression following block resolution. Trial registration NCT03749174 (clinicaltrials.gov, Nov 21, 2018, retrospectively registered).
format article
author Irén Sellbrant
Jon Karlsson
Jan G. Jakobsson
Bengt Nellgård
author_facet Irén Sellbrant
Jon Karlsson
Jan G. Jakobsson
Bengt Nellgård
author_sort Irén Sellbrant
title Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
title_short Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
title_full Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
title_fullStr Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
title_full_unstemmed Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
title_sort supraclavicular block with mepivacaine vs ropivacaine, their impact on postoperative pain: a prospective randomised study
publisher BMC
publishDate 2021
url https://doaj.org/article/5f184597ed4f4df4b4fefff5125026d6
work_keys_str_mv AT irensellbrant supraclavicularblockwithmepivacainevsropivacainetheirimpactonpostoperativepainaprospectiverandomisedstudy
AT jonkarlsson supraclavicularblockwithmepivacainevsropivacainetheirimpactonpostoperativepainaprospectiverandomisedstudy
AT jangjakobsson supraclavicularblockwithmepivacainevsropivacainetheirimpactonpostoperativepainaprospectiverandomisedstudy
AT bengtnellgard supraclavicularblockwithmepivacainevsropivacainetheirimpactonpostoperativepainaprospectiverandomisedstudy
_version_ 1718429348394958848